Archival research leads.
Original documents, library records and the next steps needed to turn a historical citation into appraisable evidence.
A located PDF, a catalogue entry and an independently verified result represent different levels of access. An author abstract is a shorter account of a dissertation, not another clinical trial. These leads are cross-linked to existing records to avoid counting the same research twice.
Pyatibrat occupational-adaptation dissertation
A. O. Pyatibrat · Minsk, 2016; 295 pages
- What was checked
- Tables 49–55, Figure 10 and selected methods/narrative; original PDF retained locally
- What remains
- Document selection from the 570-person program into its stated 320-person second stage; reconcile the 310 table total, Cortexin Group 2 counts (24 versus 34), differing uncertainty figures and statistical footnotes. Clarify allocation, harms and ethics records before pooling related reports.
Open the source or library record ↗ · Study-level evidence and limitations ↗
Stress-protective mechanisms of Bromantane and Chlodantane
Azat Rashidovich Khalimov / A. R. Khalimov · Ufa, 1997; 22-page author abstract; FB 9 98-4/2583-0 and FB 9 98-4/2584-9
- What was checked
- Russian State Library author, title, year and shelfmarks
- What remains
- Retrieve and inspect the original scan; resolve endocrine endpoints against the full dissertation. This corrects the earlier Yu. Sh. attribution, without establishing clinical efficacy.
Liberol and restoration of functional reserves under extreme exposures
Sergey Vladimirovich Padalko · Moscow, 2003; 117 pages; registration 04200309340
- What was checked
- Russian State Library catalogue and stated open-viewer availability
- What remains
- Obtain readable original pages for allocation, harms, endpoints and preparation identity. Catalogue availability is not a completed full-text appraisal.
Original Ladasten pilot report: publisher PDF route
S. A. Syunyakov and colleagues · Experimental and Clinical Pharmacology. 69(4):10–15; DOI 10.30906/0869-2092-2006-69-4-10-15
- What was checked
- Publisher metadata and indexed abstract
- What remains
- Retrieve the actual PDF behind the viewer. Enrollment, numerical findings and overlap with later neurasthenia papers remain unresolved.
Open the source or library record ↗ · Study-level evidence and limitations ↗
Bromantane pharmacokinetics: author-identity reconciliation
S. A. Medvedkova in the 2007 author bibliography; original catalogue pending · Cited as a 19-page Moscow author abstract, 1984
- What was checked
- Citation in the reproduced Vakhitova author-abstract bibliography; original cited document not inspected
- What remains
- Authenticate the original catalogue or title page. The older G. A. initials conflict with the later bibliography; no pharmacokinetic number is upgraded from this trail.
Shustov: resistance to extreme exposures in asthenia
E. B. Shustov · St. Petersburg, 1996; author abstract cited as 38 pages
- What was checked
- Existing author-abstract trail rechecked
- What remains
- Acquire the full dissertation and reconcile occupational cohorts with the 1994 conference and 1996 Maritime Medical Journal reports. The 2019 book cites 443 pages; the original catalogue and title page are needed to resolve conflicting lengths. See /shustov-research for the expanded trail.
Shustov beyond the thesis
Follow original aminoethanol and peptide-profile papers, Bemitil fumarate, ornithine and succinate reviews, and the missing 1994 conference and 1996 journal reports.
Explore the Shustov source map ↗Conference leads and repeated-report checks
9 conference retrieval trails, including three distinct Ladasten/Bromantan poster DOIs. A separate DOI or presentation is not proof of a separate experiment. Bibliographic leads remain outside the study count until the evidence itself can be appraised.
The Stemokin trail connects a journal record, dissertation account and conference reports with matching group sizes and response figures. Possible cohort reuse remains unresolved. The forum PDF’s event identity is checked separately from its hosting domain.
Ladasten transcription-factor poster P.4.001
A traceable conference record for transcription-factor research in rat brain.
Citation, collaborators and retrieval task
I. V. Vakhitova; M. Kh. Salimgareeva; R. S. Yamidanov; S. B. Seredenin
European Neuropsychopharmacology 15, S172 · DOI: 10.1016/S0924-977X(05)80354-2
Next retrieval step: Retrieve the supplement and compare against P.8.108 and the later journal reports before counting experiments. Author initials follow the deposited record.
Ladasten signaling poster P.4.023
A second identifiable conference record concerns intracellular signaling.
Citation, collaborators and retrieval task
M. Kh. Salinigareeva; I. V. Vakhitova; S. B. Seredenin, as deposited
European Neuropsychopharmacology 15, S185 · DOI: 10.1016/S0924-977X(05)80376-1
Next retrieval step: Check the original author spelling and methods; the deposited Salinigareeva spelling differs from Salimgareeva in adjacent records. No result is inferred from the title.
Bromantan transcription-factor poster P.8.108
The title closely resembles P.4.001, while using Bromantan rather than Ladasten.
Citation, collaborators and retrieval task
Authors absent from the retrieved Crossref deposit
European Neuropsychopharmacology 15, S653 · DOI: 10.1016/S0924-977X(05)81387-2
Next retrieval step: Possible repeated presentation, not established replication. Reconcile authors, meeting, methods and experimental samples with the S172 record.
Ladasten lymphocyte-response abstract
A conference trail behind the context-dependent immune-response literature.
Citation, collaborators and retrieval task
Yu. V. Vakhitova; S. V. Sibiryak
5th congress on allergology, immunology and immunopharmacology, Moscow; vol. II, p. 294, as cited
Next retrieval step: Obtain the original proceedings page and reconcile it with the published T-cell papers. The citation alone supplies no clinical autoimmune result.
Ladasten protein-kinase abstract
A retrieval target connecting the conference and subsequent signaling-paper trail.
Citation, collaborators and retrieval task
Yu. V. Vakhitova; M. Kh. Salimgareeva; S. B. Seredenin
2nd congress of the Russian Scientific Society of Pharmacologists, Moscow; p. 88, as cited
Next retrieval step: Retrieve p. 88 and establish whether later publications reuse these experiments.
Stemokin pyoderma-prevention trail
The clinical team had a prevention conference trail before the 2015 abstract.
Citation, collaborators and retrieval task
V. V. Gladko; S. A. Masyukova; N. N. Kakhishvili; D. A. Gayvoronskiy
7th conference, New in Aesthetic Dermatology: Science and Practice, Moscow; p. 122, as cited
Next retrieval step: Acquire p. 122 and reconcile enrollment and dates. Earlier appearance does not establish an additional cohort.
Stemokin at the VIII dermatovenereology and cosmetology forum
The PDF identifies the VIII forum and repeats the 39/37 treatment groups and 40/36 prevention groups. Its 2016 hosting domain does not establish the event year.
Citation, collaborators and retrieval task
V. V. Gladko; N. N. Kakhishvili; S. A. Masyukova; V. V. Savenkov
VIII International Forum of Dermatovenereologists and Cosmetologists; printed p. 63; event year unresolved
| Comparison | Reported figures |
|---|---|
| Clinical recovery, treatment comparison | 74.36% of 39 adjunct-treatment patients versus 21.62% of 37 receiving basic care |
| Pyoderma incidence, prevention comparison | 17.5% of 40 versus 58.3% of 36 over follow-up up to 12 months |
These are reported group proportions, not a modern randomized effect estimate. Concurrent care, allocation and overlap remain unresolved. Treatment and prevention populations must not be added as unique participants.
Next retrieval step: Verify front matter and cohort dates, reconcile with the 2011 dissertation and 2015 abstract, and check the inconsistent comparator response categories. Do not pool the reports as independent trials.
Pyatibrat pharmacological-support conference trail
A specific conference citation from the dissertation program.
Citation, collaborators and retrieval task
A. O. Pyatibrat; S. B. Melnov; E. D. Pyatibrat; P. D. Shabanov
Multidisciplinary Clinic of the XXI Century: Advanced Medical Technologies, St Petersburg; pp. 172–173, as cited
Next retrieval step: Retrieve the two pages and reconcile cohorts with the dissertation.
Pyatibrat metabolic-corrector conference trail
A second recoverable page range from the same program.
Citation, collaborators and retrieval task
A. O. Pyatibrat; E. D. Pyatibrat; P. D. Shabanov
Resistance to Extreme Environmental Factors, St Petersburg; pp. 17–19, as cited
Next retrieval step: Retrieve the proceedings; do not count the abstract and dissertation as independent trials.
Authors, institutions and documented connections
6 publication and institutional trails. Coauthors, scientific consultants and institution-listed cooperation are different relationships. Historical affiliations do not establish present employment, willingness to collaborate or involvement in every connected study.
Ladasten molecular-pharmacology authors
Vakhitova · Salimgareeva · Yamidanov · Seredenin; Sibiryak appears in the immune-congress citation
How the connection is documented
Coauthorship in the deposited 2005 poster metadata; the older immune citation is a retrieval lead. Names and initials have transliteration variants.
Research follow-up: Compare conference material with later journal papers; authenticate author identities before merging bibliographies.
Stemokin clinical team
V. V. Gladko · N. N. Kakhishvili · S. A. Masyukova · D. A. Gayvoronskiy; V. V. Savenkov on the forum abstract
How the connection is documented
The 2009 publisher issue lists four authors and volume 330(11):62–63. The reproduced dissertation bibliography gives two authors and volume 331: a citation conflict resolved in favor of the publisher metadata, pending the article scan.
Research follow-up: Acquire the two-page journal article and original dissertation scan. Matching figures across reports suggest possible reuse, not confirmed independent replication.
Pyatibrat’s Russia–Belarus publication trail
A. O. Pyatibrat · S. B. Melnov · P. D. Shabanov · A. S. Kozlova · N. S. Smolnik
How the connection is documented
The author abstract names Melnov and Shabanov as scientific consultants. A 2015 coauthored paper supplies historical affiliations in Belarusian sport/ecological research, EMERCOM and the Kirov Military Medical Academy.
Research follow-up: Trace original proceedings and study dates. These are documented historical roles; current availability and independent replication are unverified.
IBCh immune-peptide development and clinical links
Vladislav Deigin · Yulia Vinogradova · Dmitry Vinogradov · Marina Krasilshchikova · Vadim Ivanov
How the connection is documented
The 2021 Thymodepressin paper documents coauthorship across IBCh and Sechenov University. The former IBCh biopharmaceutical laboratory page lists institutional cooperation with rheumatology, hematology, immunology, Kirov Academy and Roswell Park; it says the unit was disbanded in 2019. Those broad links do not establish participation in each drug trial.
- 2021 original Thymodepressin publication ↗
- Historical laboratory and cooperation page ↗
- 2024 CP-88 author/affiliation record ↗
Research follow-up: Trace trial-specific investigators and reports through the named institutions. Shared developers across peptide papers do not provide independent replication.
Thymodepressin → Stemokin / Neogen → Thymogen → CP-88 → AWE18 →
Bemitil lupus clinical authors
T. A. Lisitsyna · A. D. Durnev · M. M. Ivanova · A. I. Speransky · S. B. Seredenin · V. A. Nasonova
How the connection is documented
The 1999 paper names this clinical/pharmacology team and the Institute of Rheumatology, RAMS, Moscow. This is an authorship connection, not evidence of a continuing Bemitil lupus program.
Research follow-up: Retrieve the full article and related institutional reports; reconcile the patent and paper as reports from the same research program.
Vilon diabetes and hemostasis authors
B. I. Kuznik · N. N. Kliuchereva; additional coauthors differ across the 2006 and 2007 records
How the connection is documented
Both historical diabetes papers name Kuznik and Kliuchereva. The indexed Pinelis initials differ, so identities are not silently merged. Coauthorship provides a route to the originals; it does not settle cohort overlap.
Research follow-up: Obtain both full papers and match enrollment, dates and patient characteristics before pooling results.
The highest-value acquisitions are the original Stemokin two-page article and dissertation scan, the three Ladasten poster pages and the two Pyatibrat proceedings extracts. New efficacy claims should wait for original methods and cohort reconciliation.
Recovery priorities
- Obtain complete readable source pages before transcribing tables or quoting exact pharmacokinetic estimates.
- Record the edition, document type, preparation and population. Publication dates and catalogue accession dates are different.
- Reconcile shared controls, overlapping cohorts, participant counts and allocation. A later review is not independent replication.
- Check neutral results, adverse events and discontinuations alongside positive findings.
- Authenticate commercially reproduced institute reports against originating documents; a supplier’s translation is not independent confirmation.
Original study records ↗ · Research archive ↗ · Complete bibliography ↗